As global interest in herbal medicines continues to grow, only a limited number of products are developed with rigorous scientific methods and supported by strong clinical evidence. DLBS addresses this gap through the development of Integrative Modern Natural Medicines—therapeutics based on defined bioactive fractions with clear mechanisms of action and clinically validated efficacy (phytopharmaceuticals) in accordance with Good Clinical Practice. This commitment was showcase

Dexa Medica once again demonstrates its strong commitment as a national pharmaceutical company that plays a vital role in strengthening Indonesia’s pharmaceutical independence, particularly through the development of natural-based medicines. This commitment was reflected in its active contribution to the prestigious 16th Annual Meeting of the WHO–International Regulatory Cooperation for Herbal Medicines (IRCH), held at JS Luwansa Hotel and Convention Center, Jakarta, on Tuesd

AC Health has formed a strategic alliance with Glorious Dexa Mandaya Philippines, a subsidiary of the Indonesian pharmaceutical company Dexa Group, to enhance the availability of quality and affordable medicines for Filipinos. The partnership will focus on distributing Dexa Group’s affordable medicines and healthcare products, leveraging AC Health’s integrated ecosystem, which includes over 800 Generika and St. Joseph Drug pharmacies, more than 220 clinics, six hospitals unde

Dexa Group supports Indonesia in the 2023 SEA Games in Cambodia by providing the STIMUNO Forte immunomodulator. The product helps to boost Indonesian contingents’ immunity to participate in a series of matches. This donation was given through the Embassy of the Republic of Indonesia in Phnom Penh & the Indonesian National Olympic Committee on Monday, 8 May 2023, at Rumah Indonesia, Basecamp National Olympic Committee Indonesia, Phnom Penh. 1,000 STIMUNO Forte boxes were hande

Dexa Group, a pharmaceutical company with a high international standard in Indonesia, has reaffirmed its commitment to exporting its goods to Europe. Dexa Group inked a collaboration agreement with Allgen Pharmaceutical & Generic B.V from the Netherlands and Bioton S.A from Poland through its subsidiary Ferron Par Pharmaceuticals. Allgen Pharmaceutical & Generic B.V. signed an agreement to collaborate on Wednesday, October 19, 2022, during the 2022 Trade Expo Indonesia (TEI)

The Indonesian Doctors Association inaugurated the erection of a monument named “Pengabdian Dokter Indonesia” to remember the services of doctors who died to preserve the lives of Indonesians while dealing with COVID-19. Dexa Group took part in the establishment and inauguration of the monument, which took place on Thursday, March 17, 2022, at the PB Office of the Indonesian Doctors Association (IDI), Menteng, Central Jakarta. The inauguration of the Pengabdian Dokter Indones

PT Dexa Medica won the Primaniyarta 2021 award for the New Market Pioneer category. The Primaniyarta 2021 winners’ awards were announced at the opening ceremony of the Trade Expo Indonesia Digital Edition (TEI DE), on Thursday, October 21, 2021. The President of the Republic of Indonesia, Mr. Joko Widodo (Jokowi) gave a speech at the Trade Expo Indonesia Digital Edition. In his remarks, the President emphasized the importance of continuing to innovate and increase competitive

Dexa Group, the leading pharmaceutical company from Indonesia, is ramping up its business in Southeast Asia with the launch of Glorious Dexa Singapore, Pte. Ltd. (GDS) based in Singapore. Dexa Group has exported medicines to various countries starting with Myanmar since 1993 and began exporting international standard medicines to Singapore in 2000. Through GDS, Dexa Group now leverages its contribution to Singapore’s healthcare sector. In efforts to penetrate the market and b

Summary Regdanvimab (RegkironaTM) is recommended to treat confirmed COVID-19 in adult patients who do not require supplemental oxygen therapy and are at high risk of progressing to severe COVID-19. The recommended dosage of Regdanvimab is a single intravenous infusion of 40 mg/kg. Treatment should be initiated as soon as possible after diagnosis, and not later than 7 days after the onset of symptoms. According to clinical studies, regdanvimab (RegkironaTM) significantly reduc

Dexa Medica, a leading multinational pharmaceutical company in Indonesia through its Nigerian distribution partner Orange Drugs Ltd launches a very effective and highly recommended cold and cough brand named Konos. Konos, aimed at providing relief from cold and cough disturbing and interrupting the daily lives and activities of Nigerians. At the launch of the product, held in Kano, on the 3rd of June 2021, the company’s Country Manager for Nigeria and West. Africa, Dhanang Ri